Turmeric

Meta-analysis of 6 RCTs (n=172 curcumin, n=170 placebo) found that curcumin supplementation significantly reduced circulating CRP levels (WMD=-2.20 mg/L, p<0.001), particularly at doses above 1,000 mg/day and in trials lasting 8 weeks or longer. Supports curcumin's systemic anti-inflammatory activity via NF-kB modulation.

Turmeric

Systematic review of 8 RCTs evaluating curcumin for osteoarthritis pain. Curcumin (typically 1,000 mg/day for 4-12 weeks) significantly reduced pain scores and improved physical function compared to placebo, with efficacy comparable to NSAIDs such as ibuprofen in some trials and fewer gastrointestinal side effects.

Black Pepper

Landmark crossover study in humans (n=8 per group) demonstrating that co-administration of 20 mg piperine with 2 g curcumin increased curcumin bioavailability by 2,000%. A separate arm showed 20 mg piperine increased beta-carotene bioavailability by 60%. The mechanism involves inhibition of hepatic and intestinal glucuronidation.

Black Pepper

Review of piperine's pharmacokinetic enhancement effects across multiple human and animal studies. Piperine (5-20 mg) significantly increases the bioavailability of curcumin, resveratrol, beta-carotene, CoQ10, and several pharmaceutical drugs by inhibiting CYP3A4, CYP1A1, and P-glycoprotein efflux transporters.

Turmeric

Meta-analysis of 6 RCTs (n=172 curcumin, n=170 placebo) found that curcumin supplementation significantly reduced circulating CRP levels (WMD=-2.20 mg/L, p<0.001), particularly at doses above 1,000 mg/day and in trials lasting 8 weeks or longer. Supports curcumin's systemic anti-inflammatory activity via NF-kB modulation.

Turmeric

Systematic review of 8 RCTs evaluating curcumin for osteoarthritis pain. Curcumin (typically 1,000 mg/day for 4-12 weeks) significantly reduced pain scores and improved physical function compared to placebo, with efficacy comparable to NSAIDs such as ibuprofen in some trials and fewer gastrointestinal side effects.

Cordyceps Mushroom

In a clinical trial, active adults who supplemented with Cordyceps militaris for 3 weeks showed significant improvements in VO2max compared to placebo. Clinical research shows Cordyceps supplementation significantly improves oxygen utilization during physical activity.

Reishi Mushroom

In an 84-day clinical trial, healthy adults taking Reishi β-glucan showed significant improvements in multiple immune markers, including enhanced T-cell populations and natural killer cell activity. Traditionally revered for its calming properties, Reishi has been used for centuries to support restful sleep and relaxation.

Lion's Mane Mushroom

In a 16-week clinical trial, adults with mild cognitive concerns who took 3g of Lion's Mane daily showed significant improvements in cognitive function compared to placebo. Multiple studies suggest Lion's Mane may support mental clarity through its unique ability to stimulate nerve growth factor production.

Turkey Tail Mushroom

Phase I clinical trial (n=11) evaluating Trametes versicolor (turkey tail) mushroom at escalating doses (3, 6, or 9 g/day) in women with breast cancer post-radiation. Turkey tail polysaccharopeptide (PSP) supplementation for 6 weeks significantly enhanced NK cell activity and increased CD8+ T-cell and CD19+ B-cell counts in a dose-dependent manner.

Turkey Tail Mushroom

Systematic review of 13 RCTs evaluating polysaccharide-K (PSK) and polysaccharopeptide (PSP) from Trametes versicolor as adjuvant cancer therapy. PSK (3 g/day) alongside chemotherapy significantly improved 5-year survival rates in gastric and colorectal cancer patients, mediated through beta-glucan activation of innate and adaptive immunity.

Chaga Mushroom

Chaga has been used in traditional medicine for centuries, particularly in Russia and Northern Europe. Laboratory studies have identified powerful antioxidant compounds including polyphenols and melanin. Preclinical research suggests Chaga may support the body's natural defenses against oxidative stress.

Black Pepper

Landmark crossover study in humans (n=8 per group) demonstrating that co-administration of 20 mg piperine with 2 g curcumin increased curcumin bioavailability by 2,000%. A separate arm showed 20 mg piperine increased beta-carotene bioavailability by 60%. The mechanism involves inhibition of hepatic and intestinal glucuronidation.

Black Pepper

Review of piperine's pharmacokinetic enhancement effects across multiple human and animal studies. Piperine (5-20 mg) significantly increases the bioavailability of curcumin, resveratrol, beta-carotene, CoQ10, and several pharmaceutical drugs by inhibiting CYP3A4, CYP1A1, and P-glycoprotein efflux transporters.